EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma

Aisling M Ross iD, Ciara I Leahy, Fiona Neylon, Jana Steigerova, Patrik Flodr, Martina Navratilova, Helena Urbankova iD, Katerina Vrzalikova, Lucia Mundo, Stefano Lazzi, Lorenzo Leoncini, Matthew Pugh iD und 1 weitere

Life · 14.02.2023 · 13 (2) · 521

DOI: 10.3390/life13020521 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 14.02.2023. Verfasst von Aisling M Ross und 12 weiteren Autor:innen. Beteiligte Einrichtung: Health Research Institute and School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund Project, Blood Cancer UK and the Cancer Research UK Birmingham Centre, University of Birmingham, Birmingham, United Kingdom, Blood Cancer UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein–Barr virus (EBV), defined as a group I carcinogen by the World Health Organization (WHO), is present in the tumour cells of patients with different forms of B-cell lymphoma, including Burkitt lymphoma, Hodgkin lymphoma, post-transplant lymphoproliferative disorders, and, most recently, diffuse large B-cell lymphoma (DLBCL). Understanding how EBV contributes to the development of these different types of B-cell lymphoma has not only provided fundamental insights into the underlying mechanisms of viral oncogenesis, but has also highlighted potential new therapeutic opportunities. In this review, we describe the effects of EBV infection in normal B-cells and we address the germinal centre model of infection and how this can lead to lymphoma in some instances. We then explore the recent reclassification of EBV+ DLBCL as an established entity in the WHO fifth edition and ICC 2022 classifications, emphasising the unique nature of this entity. To that end, we also explore the unique genetic background of this entity and briefly discuss the potential role of the tumour microenvironment in lymphomagenesis and disease progression. Despite the recent progress in elucidating the mechanisms of this malignancy, much work remains to be done to improve patient stratification, treatment strategies, and outcomes.

Schlagwörter

Stichwörter der Autor:innen

Epstein–Barr viruschronic inflammationdiffuse large B-cell lymphomatumour microenvironment

Autor:innen und Institutionen

  • Health Research Institute and School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland.
  • BioScience and BioEngineering Research (BioSciBer), Bernal BioMaterials Cluster, Bernal Institute, University of Limerick, V94 T9PX Limerick, Ireland.
  • Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olmouc, 775 15 Olomouc, Czech Republic.
  • Department of Clinical and Molecular Pathology, University Hospital Olomouc, 779 00 Olomouc, Czech Republic.
  • Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky Univesity and University Hospital Olomouc, 779 00 Olomouc, Czech Republic.
  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.

ORCID-Profile: Aisling M Ross, Helena Urbankova, Matthew Pugh

Förderung

  • European Regional Development Fund Project
  • Blood Cancer UK and the Cancer Research UK Birmingham Centre, University of Birmingham, Birmingham, United Kingdom
  • Blood Cancer UK
  • Cancer Research UK Birmingham Centre, University of Birmingham, Birmingham, United Kingdom
  • Marie Skłodowska-Curie Actions grant funding at the University of Limerick

Zitieren

APA

Ross, A. M., Leahy, C. I., Neylon, F., Steigerova, J., Flodr, P., Navratilova, M., Urbankova, H., Vrzalikova, K., Mundo, L., Lazzi, S., Leoncini, L., Pugh, M., & Murray, P. G. (2023). Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma. Life, 13(2), 521. https://doi.org/10.3390/life13020521

Vancouver

Ross AM, Leahy CI, Neylon F, Steigerova J, Flodr P, Navratilova M, et al. Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma. Life. 2023;13(2):521. doi:10.3390/life13020521

BibTeX
@article{Ross2023,
  author = {Ross, Aisling M and Leahy, Ciara I and Neylon, Fiona and Steigerova, Jana and Flodr, Patrik and Navratilova, Martina and Urbankova, Helena and Vrzalikova, Katerina and Mundo, Lucia and Lazzi, Stefano and Leoncini, Lorenzo and Pugh, Matthew and Murray, Paul G},
  title = {Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {521},
  doi = {10.3390/life13020521}
}
Kostenlos starten →